Best Grants for HIV / AIDS in American Samoa

Research institutions and multidisciplinary scientific teams in American Samoa studying the structural biology of HIV and other infectious diseases can apply for competitive grants from the National Institutes of Health. Funding supports advanced 3D structural analyses, molecular characterization, and structure-guided design of new diagnostics and therapeutics, which may benefit HIV/AIDS-focused programs and researchers.

American Samoa HIV/AIDS research institutions and investigators studying immunotherapies and brain health can access funding through the National Institutes of Health to evaluate how HIV immunotherapies affect central nervous system outcomes. This R21/R33 opportunity supports biphasic projects examining mechanisms, benefits, and risks, aiming to improve long-term neurologic and cognitive outcomes in people with HIV, with awards up to US $2,000,000.

Research institutions and clinical organizations conducting HIV/AIDS prevention and treatment studies in American Samoa and other eligible regions can access funding through the National Institutes of Health. Grants support participation as Clinical Trials Units within HIV/AIDS Clinical Trials Networks, including clinical research sites, implementation research, and infrastructure to recruit and retain study participants.

Research institutions with capacity to lead HIV clinical trial data operations can apply to manage Statistical and Data Management Centers serving global HIV Clinical Trials Networks, including work impacting American Samoa. American Samoa HIV / AIDS organizations partnering in clinical trials may benefit through improved data systems, monitoring, and analysis supported by the National Institutes of Health.

Research institutions and clinical laboratories working on HIV/AIDS prevention and treatment, including those serving American Samoa, can apply for National Institutes of Health support to operate HIV/AIDS Clinical Trials Network Laboratory Centers. Funding supports laboratory infrastructure, regulatory-compliant testing, data systems, and advanced assays to increase testing capacity for HIV and HIV-related diseases within multi-site clinical trials.

Research institutions focused on HIV/AIDS clinical trials and implementation research can apply to lead a Clinical Trials Network Leadership and Operations Center, including work relevant to American Samoa. Focused on HIV prevention, treatment, and cure strategies across populations, the National Institutes of Health supports LOCs providing scientific leadership and setting research priorities.

Research institutions conducting HIV/AIDS studies in American Samoa can apply for U.S. Dept. of Health & Human Services National Institutes of Health support to develop and use specific pathogen free in vivo models and human new approach methodologies. Awards US $212,004 - US $2,725,311 fund NAMs-enabled stewardship frameworks, in vitro testing support, and high-quality SPF colony operations.

Research institutions conducting interdisciplinary HIV/AIDS mental health research in American Samoa can access funding through the National Institutes of Health. Grants from the National Institutes of Health help American Samoa HIV / AIDS organizations develop and sustain coordinated research centers advancing basic, clinical, behavioral, and implementation science. Eligible centers are expected to foster collaboration and disseminate findings to agencies and affected communities.

Organizations involved in HIV/AIDS prevention, care, and planning in American Samoa can access funding to strengthen integrated HIV services and resource allocation. Focused on improving HIV care systems, the Health Resources & Services Administration provides tools, training, and technical assistance through this cooperative agreement, with awards up to US $700,000.

The AIDS Drug Assistance Program (ADAP) Emergency Relief Funds aim to provide essential funding to states and territories. This initiative focuses on preventing, reducing, or eliminating waiting lists for ADAP services, ensuring timely access to necessary medications and support for individuals living with HIV/AIDS. This program addresses critical funding shortfalls, enhancing the healthcare infrastructure and improving health outcomes in affected communities.

The Ryan White HIV/AIDS Program Part C Capacity Development Program aims to enhance the capabilities of community-based organizations, focusing on improving health outcomes and decreasing HIV transmission. This initiative supports individuals who have not yet accessed regular HIV care, emphasizing innovative care solutions and infrastructure development to address these critical needs.

The HIV Care Grant Program, funded by the US HHS: Health Resources & Services Administration (HRSA), aims to enhance access to high-quality HIV care and treatment for low-income individuals. This initiative supports states and territories in developing comprehensive systems to address the needs of those living with HIV. By providing essential resources, the program seeks to improve health outcomes and ensure that vulnerable populations receive the necessary support and services.

The Ryan White HIV/AIDS Program Part B Supplemental Grant aims to provide essential funding to support HIV care and treatment services across states and territories. This program supplements existing formula-based funding from the RWHAP Part B and ADAP, improving access to necessary resources for those affected by HIV/AIDS. By enhancing support structures, it addresses critical healthcare needs, ensuring better health outcomes for vulnerable populations.

The HIV Care Grant Program aims to enhance access to comprehensive, high-quality HIV care and treatment for low-income individuals in Pacific Island territories. Funded by the US HHS: Health Resources & Services Administration (HRSA), this initiative supports states and territories in developing effective systems of care, ensuring that those affected by HIV receive the necessary treatment and support to improve health outcomes.

This funding opportunity aims to enhance a web-based ordering portal for distributing 1.5 million HIV and STI self-tests to high-burden communities. By optimizing access to these self-tests, the initiative seeks to raise awareness, prevent new infections, and improve the health outcomes of users, thereby contributing to better overall public health and wellbeing.

This project aims to enhance health outcomes for women living with HIV in the South by integrating HIV care with comprehensive women's health services through coordinated Clinic and Community Collaboratives. By funding organizations to implement targeted strategies such as culturally responsive services and learning collaboratives, the initiative seeks to improve access to essential health services, increase the number of women initiating rapid ART, and foster sustainable healthcare models that address the unique needs of this population.

The Ryan White HIV/AIDS Program Part D provides supplemental funding aimed at enhancing the infrastructure and capacity of organizations to deliver high-quality, family-centered HIV care services. This initiative focuses on two key areas: HIV Care Innovation and Infrastructure Development, ensuring improved access to essential services for women, infants, children, and youth affected by HIV.

The Ryan White HIV/AIDS Program Part B AIDS Drug Assistance Program Training and Technical Assistance aims to enhance the capacity of ADAPs. By providing essential tools and expert guidance, the program seeks to improve health outcomes for individuals living with HIV in an evolving healthcare landscape. This initiative is funded by the US HHS through the Health Resources & Services Administration, ensuring support and resources are effectively allocated to meet the needs of vulnerable populations.

The SCORCH Program: Phase 2 aims to enhance the understanding of single cell biology in the context of HIV and Substance Use Disorder (SUD). Building on previous research, this initiative will explore new single cell approaches to investigate the interactions between SUD and HIV progression at various biological levels. By leveraging advanced techniques, the program seeks to identify candidate mechanisms and potential therapeutic targets, ultimately contributing to innovative solutions for SUDs and HIV-related challenges.

The LAST MILE program, initiated by the NIAID, aims to enhance the implementation and effectiveness of HIV prevention and treatment strategies through real-world effectiveness trials. By fostering collaborations and focusing on diverse populations, this initiative seeks to translate clinical findings into practical applications. The program supports research across various disciplines, aligning with the NIH's mission to improve HIV/AIDS outcomes and address associated comorbidities. This multifaceted approach promises to bridge the gap between clinical trials and community-based interventions.

Research institutions and clinical trial networks studying HIV in infants, children, adolescents, young adults, and maternal populations in American Samoa can access funding via the National Institutes of Health. With a mission to advance HIV and chronic illness research, NIH plans awards up to US $30,000,000 for innovative pediatric and maternal HIV clinical trials.

Biomedical and behavioral HIV researchers working in the context of substance use or substance use disorders in American Samoa can pursue high-risk, high-reward project funding through the Avant Garde Award. The US Dept. of Health & Human Services: National Institutes of Health offers US $350,000 - US $700,000 for pioneering, potentially transformative HIV and SUD research, including early stage investigators.

Research institutions and eligible organizations conducting HIV-related basic or translational studies in American Samoa can apply for up to US $275,000 to investigate biological, behavioral, or social mechanisms of HIV pathogenesis. US Dept. of Health & Human Services: National Institutes of Health supports projects on HIV comorbidities, reservoirs, and social determinants within NIDDK’s mission areas.

The NIDCD is offering funding to advance HIV/AIDS research, particularly focusing on areas related to communication disorders. This initiative supports low-risk clinical trials and encourages researchers to align their proposals with high priority topics identified by the NIH Office of AIDS Research. Applications must be submitted by the local deadline, with optional Letters of Intent due 30 days prior to the proposal deadline. This opportunity aims to enhance understanding and treatment in this crucial health area.

The Academic Research Enhancement Award (AREA) supports small-scale research grants for institutions with limited NIH funding, emphasizing biomedical research experiences for undergraduates. Eligible institutions must award baccalaureate science degrees and have received no more than $6 million in NIH support over the past seven years. This initiative aims to enhance the research environment at these institutions, fostering student involvement in research activities.

The High Priority HIV and Substance Use Research funding opportunity aims to support innovative research that addresses the intersection of HIV and substance use. Researchers are encouraged to submit proposals that include a detailed research plan and preliminary data, exploring new avenues for prevention, treatment, and potential cures for HIV among people who use drugs. Applications are due by 5 PM local time, with optional Letters of Intent recommended 30 days prior.